These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 17154104

  • 1. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y.
    Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A, Saito E, Wakabayashi T, Suzuki Y.
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
    Yamaguchi Y, Yamamoto K.
    Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
    [Abstract] [Full Text] [Related]

  • 7. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y.
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Inflammatory cytokines for osteoclastogenesis].
    Tanaka Y.
    Nihon Rinsho; 2005 Sep; 63(9):1535-40. PubMed ID: 16164208
    [Abstract] [Full Text] [Related]

  • 11. [Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis].
    Tanaka Y.
    Nihon Naika Gakkai Zasshi; 2008 Oct 10; 97(10):2377-9. PubMed ID: 19149029
    [No Abstract] [Full Text] [Related]

  • 12. A new era in rheumatoid arthritis treatment.
    Costello JC, Halverson PB.
    WMJ; 2003 Oct 10; 102(7):29-33. PubMed ID: 14711021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
    Ann Rheum Dis; 2008 Jun 10; 67(6):823-8. PubMed ID: 17644545
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic agents for rheumatoid arthritis: infliximab (a chimeric human IgG 1 monoclonal antibody to TNF-alpha) and etanercept (a soluble form of human TNF type II receptor linked to an IgG 1-Fc moietry)].
    Akiyama Y, Mimura T.
    Masui; 2006 Jul 10; 55(7):864-72. PubMed ID: 16856547
    [Abstract] [Full Text] [Related]

  • 17. [Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
    Suzuki Y.
    Clin Calcium; 2007 Dec 10; 17(12):1909-13. PubMed ID: 18057668
    [Abstract] [Full Text] [Related]

  • 18. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
    Okada Y, Nawata M, Tanaka Y.
    Clin Calcium; 2009 Aug 10; 19(8):1186-90. PubMed ID: 19638703
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein].
    Fujikawa K, Kawakami A, Eguchi K.
    Nihon Rinsho; 2007 Jul 10; 65(7):1211-7. PubMed ID: 17642234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.